Poolbeg Pharma Share Discussion Threads

[adorling] 25/4/2024 09:22

Had a margin call Sikho?

[muchodinero] 24/4/2024 21:11

Lol, yeah Sickothetech the nutter will say it's a small punt from retail investor buying 950,000 shares at 11.90p..he's still dripping poison on the LSE boards..very sick individual or professional troll

[discojames] 24/4/2024 18:15

Someone's just bought £113k at an all time high.

...Stt will still say its just small trades and private investor ramping haha

[sikhthetech] 24/4/2024 16:33

The rise today was on the back of yet another Podcast!!

Not news driven then.

[inaminute] 24/4/2024 15:34

Cannot see what it says but I bet the fool is twisted today :D

[sikhthetech] 24/4/2024 15:12

Adorling,

What news you're expecting?
I haven't seen anything to suggest significant news is imminent.

Nearly 3 years since IPO!!.
Increasing costs, yet nil revenues, as of latest published AR, fy2022).

If I thought significant news was expected, I'd think about changing my assertion that these are significantly overvalued.

[adorling] 24/4/2024 15:04

Hope you are not short Sikh as there could be some margin calls coming?

[sikhthetech] 24/4/2024 14:57

1gw,

Like you and your mates Byot (down 99%), Trmr(down 80%), Rthm(down 80%) etc etc.

Small trades to push the share price higher to entice gullible posters in thinking there's good news...

Nothing new, is it?

[1gw] 24/4/2024 14:53

This is all very nice but the price action feels both real (i.e. some genuine albeit relatively small scale buying interest) and a bit suspect (i.e. what has changed recently?).

If anything I would have thought the apparent delay to results might make investors a bit reluctant at this stage. So does somebody know something?

[sikhthetech] 24/4/2024 14:52

adorling,

What good news?

You claiming investors are buying using insider information?
Really!!


There's lots of small trades to push the share price higher, nothing new, is it?
Same PIs churning trades.

As of latest AR, fy2022.
Revenue NIL,

Current mcap £57m

[adorling] 24/4/2024 14:41

1 year Breakout on strong volume is encouraging - is good news about to land?

[peterrr3] 19/4/2024 14:33

Each to their own, I tend to look at the fundamentals and management history as they will always follow the same path if it worked before. There is a phase 2 oral being recruited by the opposition with 4 1/2 year time line. This will be dutifully ignored, which is what I like about Poolbeg management.

[muchodinero] 19/4/2024 11:58

Peterrrrr...how is your pal Maryb the ramping nun getting on with VANQ? Oh dear..

[peterrr3] 19/4/2024 11:16

Baby biotech can only really move on hype before phase 2 done, nothing special here.

[peterrr3] 19/4/2024 10:36

Accounts are going to have little bearing I reckon as any pipeline progress is going to be flagged in an RNS up front. I saw some update on one of the patent applications a few days ago on Wipo but it looked like a standard 3rd party review request , so nothing special.

[baldrick1] 19/4/2024 10:31

There is money to be made on shares with zero revenue and only on hypes..weird markets .:))

[eeza] 19/4/2024 10:29

Need to upgrade from Abacus.

[1gw] 19/4/2024 10:05

Remarkably quiet here, given the chart. Apparently delayed results not weighing on the price at the moment.

[pgaffney] 18/4/2024 10:48

And a mountain of debt

[blackhorse23] 18/4/2024 10:25

AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION

[inaminute] 15/4/2024 12:49

It is one of their top priorities for this year

[burtond1] 15/4/2024 10:37

Great this for #POLB Very positive to see the approval of multiple CAR T cell therapies for earlier treatment of multiple myelomaAs an oral preventative therapy for CRS #POLB 001 has the potential to enable broader, safer delivery of cancer immunotherapies to cancer patientshttps://x.com/PoolbegPharma/status/1779751510999752894

[chica1] 12/4/2024 14:45

How do u come to that conclusion?
No point in going to the Nasdaq unless you're very very well capitalised.
I'd say a Phase 2 Clinical trial will be necessary expecially since cytokine storm can effect multiple organs

[inaminute] 12/4/2024 14:00

This will be on Nasdaq by year end